Advertisement

Cell and Tissue Research

, Volume 369, Issue 2, pp 303–312 | Cite as

Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4

  • Keywan Mortezaee
  • Neda Khanlarkhani
  • Fatemeh Sabbaghziarani
  • Saeid Nekoonam
  • Jamal Majidpoor
  • Amir Hosseini
  • Parichehr Pasbakhsh
  • Iraj Ragerdi KashaniEmail author
  • Adib Zendedel
Regular Article

Abstract

Preconditioning of mesenchymal stem cells (MSCs) with melatonin (MT) has shown promising results in animal models of myocardial infarction, renal ischemia and cerebral ischemia. Here, we use this strategy in the liver fibrosis induced by CCl4. There were five groups: normal, CCl4, CCl4 + vehicle, CCl4 + BMMSCs and CCl4 + MT-bone marrow (BM)-derived MSCs (MT-BMMSCs). CCl4 was injected twice weekly for 8 weeks and treatment either with cells or vehicle was performed at the beginning of week 5 with a single dose. BMMSCs were preconditioned with MT for 24 h before injection. MT-BMMSCs had a high ability of homing into the injured liver (P ≤ 0.05 vs. BMMSCs). The CCl4 + MT-BMMSCs group showed higher percentage of glycogen storage but lower percentage of collagen and lipid accumulation (P ≤ 0.05 vs. CCl4 + BMMSCs). The CCl4 + MT-BMMSCs group showed lower expressions of transforming growth factor-β1 (TGF-β1) and Bax and lower content of sera alanine aminotransferase (ALT) but higher expressions of matrix metalloproteinases (MMPs) and Bcl2 compared with the BMMSCs group (P ≤ 0.05). The results showed the better therapeutic outcomes of MT preconditioning by probably improving cell homing and also better maintenance of the balance between matrix degrading and accumulating factors.

Keywords

Preconditioning Melatonin Bone marrow-derived mesenchymal stem cells Liver Matrix metalloproteinase 

Notes

Acknowledgements

This study was supported in part by grant 93-02-30-25909 from the Tehran University of Medical Sciences.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest.

References

  1. Abdel-Salam OM, Sleem AA, Morsy FA (2007) Effects of biphenyldimethyl-dicarboxylate administration alone or combined with silymarin in the CCl 4 model of liver fibrosis in rats. Sci World J 7:1242–1255CrossRefGoogle Scholar
  2. Augusti K, Anuradha PS, Smitha K, Sudheesh M, George A, Joseph M (2005) Nutraceutical effects of garlic oil, its nonpolar fraction and a Ficus flavonoid as compared to vitamin E in CCl4 induced liver damage in rats. Indian J Exp Biol 43:437–444PubMedGoogle Scholar
  3. Calleja MA, Vieites JM, Montero-Meterdez T, Torres MI, Faus MJ, Gil A, Suárez A (2013) The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation. Br J Nutr 109:394–401CrossRefPubMedGoogle Scholar
  4. Gutiérrez R, Alvarado JL, Presno M, Pérez‐Veyna O, Serrano CJ, Yahuaca P (2010) Oxidative stress modulation by Rosmarinus officinalis in CCl4‐induced liver cirrhosis. Phytother Res 24:595–601CrossRefPubMedGoogle Scholar
  5. Hardjo M, Miyazaki M, Sakaguchi M, Masaka T, Ibrahim S, Kataoka K, N-h H (2009) Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplant 18:89–99CrossRefPubMedGoogle Scholar
  6. Huang G-J, Deng J-S, Chiu C-S, Liao J-C, Hsieh W-T, Sheu M-J, Wu C-H (2011) Hispolon protects against acute liver damage in the rat by inhibiting lipid peroxidation, proinflammatory cytokine, and oxidative stress and downregulating the expressions of iNOS, COX-2, and MMP-9. Evid Based Complement Alternat Med. doi: 10.1155/2012/480714 Google Scholar
  7. Hwang IS, Kim JE, Lee YJ, Kwak MH, Choi YH, Kang BC, Hong JT, Hwang DY (2013) Protective effects of gomisin A isolated from Schisandra chinensis against CCl4-induced hepatic and renal injury. Int J Mol Med 31:888–898PubMedGoogle Scholar
  8. Lee SJ, Jung YH, Oh SY, Yun SP, Han HJ (2014) Melatonin enhances the human mesenchymal stem cells motility via melatonin receptor 2 coupling with Gαq in skin wound healing. J Pineal Res 57:393–407CrossRefPubMedGoogle Scholar
  9. Li Q, Yu P, Wang W, Zhang P, Yang H, Li S, Zhang L (2014) Gene expression profiles of various cytokines in mesenchymal stem cells derived from umbilical cord tissue and bone marrow following infection with human cytomegalovirus. Cell Mol Biol Lett 19:140–157PubMedGoogle Scholar
  10. Luchetti F, Betti M, Canonico B, Arcangeletti M, Ferri P, Galli F, Papa S (2009) ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells. Free Radic Biol Med 46:339–351CrossRefPubMedGoogle Scholar
  11. Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat‐George F, Sabatier F, Piercecchi‐Marti MD, Daniel L, Bianchi P, Calise D (2008) Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26:1749–1757CrossRefPubMedGoogle Scholar
  12. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, Ordener C, Piercecchi‐Marti MD, Auge N, Salvayre AN (2009) Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 27:2734–2743CrossRefPubMedGoogle Scholar
  13. Mortezaee K, Minaii B, Sabbaghziarani F, Kashani IR, Hassanzadeh G, Pasbakhsh P, Barbarestani M, Latifpour M (2015a) Retinoic acid as the stimulating factor for differentiation of Wharton’s Jelly-Mesenchymal stem cells into hepatocyte-like cells. Avicenna J Med Biotechnol 7:106–112PubMedPubMedCentralGoogle Scholar
  14. Mortezaee K, Sabbaghziarani F, Omidi A, Dehpour AR, Omidi N, Ghasemi S, Pasbakhsh P, Ragerdi Kashani I (2015b) Therapeutic value of melatonin post-treatment on CCl4-induced fibrotic rat liver. Can J Physiol Pharmacol 94:1–12CrossRefGoogle Scholar
  15. Mortezaee K, Pasbakhsh P, Ragerdi KI, Sabbaghziarani F, Omidi A, Zendedel A, Ghasemi S, Dehpour A (2016) Melatonin pretreatment enhances the homing of bone marrow-derived mesenchymal stem cells following transplantation in a rat model of liver fibrosis. Iran Biomed J 20:207–216PubMedPubMedCentralGoogle Scholar
  16. Motawi TMK, Atta HM, Sadik NAH, May A (2014) The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis. Cell Biochem Biophys 68:111CrossRefPubMedGoogle Scholar
  17. Park J-H, Lee M-K, Yoon J (2015) Gamma-linolenic acid inhibits hepatic PAI-1 expression by inhibiting p38 MAPK-dependent activator protein and mitochondria-mediated apoptosis pathway. Apoptosis 20:336–347CrossRefPubMedGoogle Scholar
  18. Ren G, Zhao X, Zhang L, Zhang J, L’Huillier A, Ling W, Roberts AI, Le AD, Shi S, Shao C (2010) Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184:2321–2328CrossRefPubMedPubMedCentralGoogle Scholar
  19. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K (2004) Transplantation of bone marrow cells reduces CCl4‐induced liver fibrosis in mice. Hepatology 40:1304–1311CrossRefPubMedGoogle Scholar
  20. Stern P, Furukawa T, Brody T (1965) Rat liver and plasma lipids after carbon tetrachloride administration. J Lipid Res 6:278–286PubMedGoogle Scholar
  21. Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B (2001) Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 98:2108–2115CrossRefPubMedGoogle Scholar
  22. Tang Y, Cai B, Yuan F, He X, Lin X, Wang J, Wang Y, Yang GY (2013) Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant 23:1279–91CrossRefGoogle Scholar
  23. Tang Y, Cai B, Yuan F, He X, Lin X, Wang J, Wang Y, Yang G-Y (2014) Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant 23:1279–1291CrossRefPubMedGoogle Scholar
  24. Tanimoto H, Terai S, Taro T, Murata Y, Fujisawa K, Yamamoto N, Sakaida I (2013) Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res 354:717–728CrossRefPubMedGoogle Scholar
  25. Verrecchia F, Mauviel A (2007) Transforming growth factor-beta and fibrosis. World J Gastroenterol 13:3056–3062PubMedPubMedCentralGoogle Scholar
  26. Watanabe T, Niioka M, Hozawa S, Kameyama K, Hayashi T, Arai M, Ishikawa A, Maruyama K, Okazaki I (2000) Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 33:224–235CrossRefPubMedGoogle Scholar
  27. Zhang HM, Zhang Y (2014) Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions. J Pineal Res 57:131–146CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • Keywan Mortezaee
    • 1
  • Neda Khanlarkhani
    • 2
  • Fatemeh Sabbaghziarani
    • 3
  • Saeid Nekoonam
    • 2
  • Jamal Majidpoor
    • 4
  • Amir Hosseini
    • 4
  • Parichehr Pasbakhsh
    • 2
  • Iraj Ragerdi Kashani
    • 2
    Email author
  • Adib Zendedel
    • 5
  1. 1.Department of Anatomy, School of MedicineKurdistan University of Medical SciencesSanandajIran
  2. 2.Department of Anatomy, School of MedicineTehran University of Medical SciencesTehranIran
  3. 3.Department of Anatomy, School of MedicineQazvin University of Medical SciencesQazvinIran
  4. 4.Department of Anatomy, School of MedicineIran University of Medical SciencesTehranIran
  5. 5.Institute of Neuroanatomy, School of MedicineRWTH Aachen UniversityAachenGermany

Personalised recommendations